Thomas Lynch was named chief scientific officer at Bristol-Myers Squibb.
The NCCN Oncology Research Program has awarded grants for its first-ever multi-industry collaborative project, soliciting investigator-initiated proposals to research the effectiveness of Boehringer Ingelheim's afatinib in combination with other drugs to treat lung and head and neck cancers.
By the time its annual conference concludes on March 25, the National Comprehensive Cancer Network aims to have 100 medical centers and practices that deliver chemotherapy committed to Just Bag It: The NCCN Campaign for Safe Vincristine Handling.
European Society For Medical Oncology said it will take over the organization of the Targeted Anticancer Therapies Congress, with the aim of expanding its educational offer and ensure that professionals are kept up-to-date with the latest drug developments to improve outcomes for cancer patients.
CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology, and the Oncology Nursing Society announced the formation of the CancerLinQ Ambassadors Program.
Boone Hospital Center, one of Missouri's top hospitals and part of BJC HealthCare, is the first affiliate in the network and will work with Siteman Cancer Center to provide access to cancer prevention and control strategies and genomic and genetic testing in the mid-Missouri area.
The Karmanos Cancer Institute and Wayne State University School of Medicine will launch the nation's largest study of African American cancer survivors to better understand disproportionately high incidence and mortality from cancer and its impact on this specific patient population.
Sheldon M. Feldman was named chief of the division of breast surgery and surgical oncology, and director of Breast Cancer Services at Montefiore Einstein Center for Cancer Care, the clinical arm of the Albert Einstein Cancer Center.
Michael Rosen was named chief communications officer at the Pancreatic Cancer Action Network.
After three rounds of competition — one of which involved a public vote — a software tool developed by researchers at Fred Hutchinson Cancer Research Center and the University of Basel to track Zika, Ebola and other viral disease outbreaks in real time has won the first-ever international Open Science Prize.
